Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMD

This study has been completed.

Study NCT00065728 Information provided by Alcon Research

First Received: July 31, 2003 Last Updated: May 7, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Primary Completion Date:	September 2008 (Final data collection date for primary outcome measure)